Teladoc Health Price to Sales Ratio 2014-2024 | TDOC
Historical PS ratio values for Teladoc Health (TDOC) over the last 10 years. The current P/S ratio for Teladoc Health as of May 07, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Teladoc Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-07 | 6.86 | 0.45 | |
| 2024-12-31 | 9.09 | $15.12 | 0.60 |
| 2024-09-30 | 9.18 | $15.37 | 0.60 |
| 2024-06-30 | 9.78 | $15.64 | 0.63 |
| 2024-03-31 | 15.10 | $15.84 | 0.95 |
| 2023-12-31 | 21.55 | $15.85 | 1.36 |
| 2023-09-30 | 18.59 | $15.78 | 1.18 |
| 2023-06-30 | 25.32 | $15.57 | 1.63 |
| 2023-03-31 | 25.90 | $15.26 | 1.70 |
| 2022-12-31 | 23.65 | $14.92 | 1.58 |
| 2022-09-30 | 25.35 | $14.50 | 1.75 |
| 2022-06-30 | 33.21 | $14.00 | 2.37 |
| 2022-03-31 | 72.13 | $13.55 | 5.32 |
| 2021-12-31 | 91.82 | $13.01 | 7.06 |
| 2021-09-30 | 126.81 | $13.71 | 9.25 |
| 2021-06-30 | 166.29 | $13.90 | 11.97 |
| 2021-03-31 | 181.75 | $13.82 | 13.15 |
| 2020-12-31 | 199.96 | $13.31 | 15.03 |
| 2020-09-30 | 219.24 | $11.25 | 19.49 |
| 2020-06-30 | 190.84 | $9.71 | 19.66 |
| 2020-03-31 | 155.01 | $8.37 | 18.51 |
| 2019-12-31 | 83.72 | $7.72 | 10.84 |
| 2019-09-30 | 67.72 | $7.41 | 9.14 |
| 2019-06-30 | 66.41 | $7.12 | 9.33 |
| 2019-03-31 | 55.60 | $6.80 | 8.17 |
| 2018-12-31 | 49.57 | $6.44 | 7.69 |
| 2018-09-30 | 86.35 | $5.97 | 14.46 |
| 2018-06-30 | 58.05 | $5.56 | 10.44 |
| 2018-03-31 | 40.30 | $4.87 | 8.27 |
| 2017-12-31 | 34.85 | $4.25 | 8.21 |
| 2017-09-30 | 33.15 | $3.74 | 8.87 |
| 2017-06-30 | 34.70 | $3.23 | 10.75 |
| 2017-03-31 | 25.00 | $3.10 | 8.08 |
| 2016-12-31 | 16.50 | $2.97 | 5.55 |
| 2016-09-30 | 18.31 | $3.22 | 5.68 |
| 2016-06-30 | 16.02 | $3.07 | 5.21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.189B | $2.570B |
| Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.013B | 25.51 |
| Elevance Health (ELV) | United States | $93.532B | 12.07 |
| CVS Health (CVS) | United States | $83.782B | 10.41 |
| Cencora (COR) | United States | $56.393B | 20.47 |
| Natera (NTRA) | United States | $21.021B | 0.00 |
| DiDi Global (DIDIY) | China | $20.473B | 31.07 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.189B | 0.00 |
| CochLear (CHEOY) | Australia | $11.336B | 0.00 |
| Solventum (SOLV) | United States | $11.327B | 10.56 |
| ICON (ICLR) | Ireland | $10.910B | 10.14 |
| Revvity (RVTY) | United States | $10.864B | 18.34 |
| Doximity (DOCS) | United States | $10.660B | 55.44 |
| Viatris (VTRS) | United States | $10.056B | 3.20 |
| Medpace Holdings (MEDP) | United States | $8.300B | 22.04 |
| Avantor (AVTR) | United States | $8.164B | 11.86 |
| Sonic Healthcare (SKHHY) | Australia | $8.076B | 0.00 |
| HealthEquity (HQY) | United States | $7.797B | 38.36 |
| Charles River Laboratories (CRL) | United States | $5.668B | 11.18 |
| Amplifon S.p.A (AMFPF) | Italy | $4.736B | 25.00 |
| Bausch + Lomb (BLCO) | Canada | $3.852B | 22.71 |
| BrightSpring Health Services (BTSG) | United States | $3.804B | 35.21 |
| Sotera Health (SHC) | United States | $3.648B | 20.73 |
| Alignment Healthcare (ALHC) | United States | $3.110B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.950B | 33.84 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| Organon (OGN) | United States | $2.373B | 2.52 |
| Premier (PINC) | United States | $2.095B | 14.34 |
| Progyny (PGNY) | United States | $2.001B | 44.08 |
| Ardent Health Partners (ARDT) | United States | $1.857B | 7.93 |
| Agilon Health (AGL) | United States | $1.842B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.776B | 69.53 |
| GoodRx Holdings (GDRX) | United States | $1.634B | 35.50 |
| PACS (PACS) | United States | $1.503B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 9.46 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.952B | 0.00 | |
| CareDx (CDNA) | United States | $0.790B | 12.33 |
| AMN Healthcare Services Inc (AMN) | United States | $0.748B | 5.92 |
| Nutex Health (NUTX) | United States | $0.735B | 14.39 |
| Embecta (EMBC) | United States | $0.710B | 4.86 |
| QDM (QDMI) | Hong Kong, SAR China | $0.671B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 13.73 |
| Sonida Senior Living (SNDA) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 38.29 |
| InnovAge Holding (INNV) | United States | $0.385B | 0.00 |
| LifeMD (LFMD) | United States | $0.341B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.338B | 0.00 |
| SBC Medicals (SBC) | United States | $0.323B | 0.00 |
| DocGo (DCGO) | United States | $0.239B | 9.75 |
| Oncology Institute (TOI) | United States | $0.197B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.177B | 0.00 |
| Beauty Health (SKIN) | United States | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.089B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.083B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| ModivCare (MODV) | United States | $0.020B | 7.10 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |